SlideShare a Scribd company logo
1 of 25
Susan Thomas
CHC, CIA, CRMA, CPC
Compliance Manager-PYA
2018 KHIMA ANNUAL MEETING
In the Patient’s Best Interest:
Updated HIPAA Guidance Targeted
for the Opioid Crisis
Prepared for 2018 KHIMA Annual Meeting Page 1
Objectives
 Review of HIPAA privacy standards
 Define “in the patient’s best interest”
 The opioid crisis
 Features of the updated guidance
 Application considerations
 Great! Now what do we do?
Prepared for 2018 KHIMA Annual Meeting Page 2
HIPAA Privacy Standards
 The privacy standards define the boundaries for the
appropriate use of health information to support
TPO:
 Treatment
 Payment
 Operations
 Under HIPAA, healthcare providers must:
 Notify patients of privacy rights
 Allow patients to see their medical records
 Implement privacy procedures
 Provide training for employees
 Designate an individual to be responsible for seeing that
privacy procedures are adopted and followed
 Keep patient records secure
Prepared for 2018 KHIMA Annual Meeting Page 3
HIPAA Privacy Standards
Covered
Entities
Healthcare
Organizations
Healthcare
Plans/Payers
Healthcare
Clearinghouse
 At the core of HIPAA is the definition of
covered entities to whom it pertains
 A covered entity is a healthcare
organization such as a provider,
a healthcare clearinghouse, or
a healthcare plan such as
Medicare or commercial
payers
 The HIPAA Standards
require covered entities to:
 Implement privacy procedures and
train their employees to follow the
procedures
 Designate an individual to be
responsible for ensuring that the
privacy procedures are followed
 Secure patient records so they are not
easily accessible to those who do not
need them
Prepared for 2018 KHIMA Annual Meeting Page 4
In the Patient’s Best Interest
 A fundamental consideration:
 Patient autonomy meets medical responsibility
 The balance of protection from harm with the provision
of necessary services
 Who says?
 The attending physician often holds the ultimate
responsibility to determine if a patient is able to make
sound healthcare decisions
 The courts may be involved which can be time-
consuming and dramatic
 Advanced directives and surrogate decision-making
Prepared for 2018 KHIMA Annual Meeting Page 5
In the Patient’s Best Interest
 Healthcare providers often find themselves faced
with circumstances in which they have to make
decisions for an incapacitated patient
 Nowhere is the issue of protection versus provision
more evident than in the midst of the opioid crisis
Prepared for 2018 KHIMA Annual Meeting Page 6
The Opioid Crisis
 The opioid epidemic is the leading cause of death in the
U.S. among adults under 501
 Life expectancy in the U.S. fell for the second year in a
row in 2016 – attributed to fatal opioid overdoses2
 Emergency Department visits for opioid overdose up 30%
in 20173
 Drugs include hydrocodone (Vicodin), oxycodone
(OxyContin), morphine, codeine, fentanyl, methadone,
heroin
 Can be taken orally, injected, inhaled, and/or smoked
1. https://www.nytimes.com/interactive/2017/06/05/upshot/opioid-epidemic-drug-overdose-deaths-are-rising-faster-than-
ever.html.
2. https://www.pri.org/stories/2017-12-21/us-life-expectancy-fell-2016-second-year-row.
3. https://www.cnn.com/2018/03/06/health/opioid-overdose-emergency-departments-cdc-study/index.html.
Prepared for 2018 KHIMA Annual Meeting Page 7
The Opioid Crisis
 In 2012, 259 million prescriptions were written for
opioids, which is more than enough to give every
American adult their own bottle of pills4
 Four in five new heroin users started out by misusing
prescription painkillers5
4. Centers for Disease Control and Prevention. (2014). Opioid Painkiller Prescribing, Where You Live Makes a Difference.
Atlanta, GA: Centers for Disease Control and Prevention. Available at http://www.cdc.gov/vitalsigns/opioid-prescribing/.
5. Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United
States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013 Sep 1;132(1-2):95-100. doi:
10.1016/j.drugalcdep.2013.01.007. Epub 2013 Feb 12.
Prepared for 2018 KHIMA Annual Meeting Page 8
The Opioid Crisis
Opioid addiction does not discriminate
 Adolescents (12 to 17 years old)6
 The prescribing rates for prescription opioids among
adolescents and young adults nearly doubled from
1994 to 2007
 Most adolescents who misuse prescription pain
relievers are given them for free by a friend or relative
6. https://www.asam.org/docs/default-source/advocacy/opioid-addiction-disease-facts-figures.pdf.
Prepared for 2018 KHIMA Annual Meeting Page 9
The Opioid Crisis
Opioid addiction does not discriminate
 Women7
 Women are more likely to have chronic pain, be
prescribed prescription pain relievers, be given higher
doses, and use them for longer time periods than men
 Women may become dependent on prescription pain
relievers more quickly than men
 48,000 women died of prescription pain reliever
overdoses between 1999 and 2010
7. Centers for Disease Control and Prevention. (2013). Prescription Painkiller Overdoses: A Growing Epidemic, Especially
Among Women. Atlanta, GA: Centers for Disease Control and Prevention. Available at
http://www.cdc.gov/vitalsigns/prescriptionpainkilleroverdoses/index.html.
Prepared for 2018 KHIMA Annual Meeting Page 10
The Opioid Crisis
Opioid addiction does not discriminate
 Elderly8
 Older adults use more prescription drugs than do any
other age group
 Elderly patients often see multiple healthcare providers
and obtain multiple prescriptions
 Over 40% of older adults have chronic pain that is
often treated with opioids, sometimes for long periods
of time
 Opioid use among older adults increases risk for falls,
delirium, fractures, pneumonia, and all-cause mortality
8. https://www.aarp.org/content/dam/aarp/ppi/2017/07/prescription-drug-abuse-among-older-adults.pdf.
Prepared for 2018 KHIMA Annual Meeting Page 11
Features of the Updated Guidance
 Current HIPAA regulations allow healthcare providers
to share information in certain emergency or
dangerous situations
 Misunderstandings about HIPAA can create obstacles
to family support that is crucial to the proper care and
treatment of a crisis situation
Prepared for 2018 KHIMA Annual Meeting Page 12
Features of the Updated Guidance
 Newly released HIPAA guidelines from OCR include:
 Sharing information related to mental health and
substance use disorder treatment with a patient's
family, friends, and others involved in the patient’s
care or payment for care
 Collaboration with HHS partner agencies to identify
and develop model programs and materials for
training related to mental health or substance use
disorder treatment
 HIPAA and research, as called for in the Cures Act
 Launch of a working group to study use of Protected
Health Information, or PHI, for research purposes
Prepared for 2018 KHIMA Annual Meeting Page 13
Features of the Updated Guidance
 The role that caregivers provide to individuals with
a substance abuse disorder in support of treatment
and recovery
 Must be able to notify caregivers in emergency
situations and coordinate care for acute and
ongoing treatment
Prepared for 2018 KHIMA Annual Meeting Page 14
Application Considerations
 PHI can be shared with a patient’s relatives or
friends who are involved in the patient’s care, or if
the sharing is necessary to identify, locate, or notify
family members
 Incapacitation: An unfortunate, but important
information-sharing issue to address with substance
abuse
Prepared for 2018 KHIMA Annual Meeting Page 15
Application Considerations
 Family and close friends involved in the care of the
incapacitated patient are allowed to obtain specifically
related information if the release of information is in
the best interest of the patient
 Sharing unrelated medical information is never
allowed without the patient’s permission
 If the patient poses a serious and imminent health and
safety threat, healthcare providers can inform family,
friends, or caregivers to prevent or lessen the
likelihood of harm
Prepared for 2018 KHIMA Annual Meeting Page 16
Application Considerations
 A patient’s incapacity may be temporary, requiring
healthcare providers to use their professional
judgement
 If the patient has capacity, the patient has the right to
object to further disclosures of information
 The provider may still share information with the
patient’s friends or family under the “threat to health
or safety” circumstances
Prepared for 2018 KHIMA Annual Meeting Page 17
Great! Now what do we do?
 New guidance does not include new statutory
requirements
 Helps debunk persistent myths about what type of
information can be shared with family members and
others
 Describes when PHI can be shared in the urgent
situations caused by substance abuse
Prepared for 2018 KHIMA Annual Meeting Page 18
 OCR’s updated HIPAA guidance DOES NOT
supersede state laws or other federal guidelines,
including the federal confidentiality regulations (i.e.,
42 CFR Part 2)
 The “Part 2” regulations pertain to patient records
maintained in connection with certain federally
assisted substance use disorder treatment programs
 Part 2 could prohibit some, or all, of the disclosures
which OCR has now clarified are permitted under
HIPAA
Great! Now what do we do?
Prepared for 2018 KHIMA Annual Meeting Page 19
Great! Now what do we do?
 Provide the updated guidance information with
emergency room physicians, nurses,
clinicians, and facilities who treat persons with
substance abuse problems
Prepared for 2018 KHIMA Annual Meeting Page 20
Great! Now what do we do?
Fact Sheets
Prepared for 2018 KHIMA Annual Meeting Page 21
Great! Now what do we do?
 Examine
organizational policies
and procedures to
properly balance the
protection of privacy
with providing care in
the best interest of the
patient
Image Source: (2017) Justice Pixabay #311699, Pixabay.com.
Prepared for 2018 KHIMA Annual Meeting Page 22
Closing thoughts . . .
“HHS is using every tool at its disposal to help communities
devastated by opioids including educating families and doctors
on how they can share information to help save the lives of
loved ones.”
– Roger Severino, Director of OCR
“When someone is unconscious, you should violate their
privacy to save a life.”
– Dr. Deborah Peel, Founder and President, Patient Privacy Rights
“I don’t think we should make it right to kill yourself easily
without the intervention of your loved ones.”
– Governor Chris Christie, Chairman of the President’s Opioid Commission
Prepared for 2018 KHIMA Annual Meeting Page 23
Questions?
Image Source: (2017) Questions Pixabay #1090830, Pixabay.com.
Prepared for 2018 KHIMA Annual Meeting Page 24
THANK YOU!
Susan Thomas
CHC,® CIA, CRMA, CPC®
Manager – PYA, P.C.
sthomas@pyapc.com

More Related Content

What's hot

Rx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinRx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinOPUNITE
 
Rx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanRx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanOPUNITE
 
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchRx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynoteOPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriendRx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriendOPUNITE
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerOPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
 
Mystified by MAT? Navigating the Changing Regulatory Landscape Around Medicat...
Mystified by MAT? Navigating the Changing Regulatory Landscape Around Medicat...Mystified by MAT? Navigating the Changing Regulatory Landscape Around Medicat...
Mystified by MAT? Navigating the Changing Regulatory Landscape Around Medicat...Epstein Becker Green
 
Rx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyRx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyOPUNITE
 
Rx16 tpp tues_200_1_bartlett-peak_2fisher
Rx16 tpp tues_200_1_bartlett-peak_2fisherRx16 tpp tues_200_1_bartlett-peak_2fisher
Rx16 tpp tues_200_1_bartlett-peak_2fisherOPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerOPUNITE
 
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armaganRx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armaganOPUNITE
 
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdevaRx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdevaOPUNITE
 
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleRx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleOPUNITE
 
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4travenRx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4travenOPUNITE
 
Rx16 federal tues_200_1_gladden_2halpin_3green
Rx16 federal tues_200_1_gladden_2halpin_3greenRx16 federal tues_200_1_gladden_2halpin_3green
Rx16 federal tues_200_1_gladden_2halpin_3greenOPUNITE
 
Rx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manloveRx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manloveOPUNITE
 
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonickRx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonickOPUNITE
 

What's hot (20)

Rx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinRx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorin
 
Rx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanRx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gorman
 
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchRx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriendRx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriend
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2waller
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Mystified by MAT? Navigating the Changing Regulatory Landscape Around Medicat...
Mystified by MAT? Navigating the Changing Regulatory Landscape Around Medicat...Mystified by MAT? Navigating the Changing Regulatory Landscape Around Medicat...
Mystified by MAT? Navigating the Changing Regulatory Landscape Around Medicat...
 
Rx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyRx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashley
 
Rx16 tpp tues_200_1_bartlett-peak_2fisher
Rx16 tpp tues_200_1_bartlett-peak_2fisherRx16 tpp tues_200_1_bartlett-peak_2fisher
Rx16 tpp tues_200_1_bartlett-peak_2fisher
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armaganRx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
 
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdevaRx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
 
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleRx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
 
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4travenRx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
 
Rx16 federal tues_200_1_gladden_2halpin_3green
Rx16 federal tues_200_1_gladden_2halpin_3greenRx16 federal tues_200_1_gladden_2halpin_3green
Rx16 federal tues_200_1_gladden_2halpin_3green
 
Rx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manloveRx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manlove
 
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonickRx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
 

Similar to In the Patient's Best Interest: Updated HIPAA Guidance Targeted for the Opioid Crisis

Covid 19-survey PWC
Covid 19-survey PWCCovid 19-survey PWC
Covid 19-survey PWCTrustRobin
 
Tx 2 joint presentation
Tx 2 joint presentationTx 2 joint presentation
Tx 2 joint presentationOPUNITE
 
Przybysz, reinhardt ph rgroupproject_fall_2012
Przybysz, reinhardt ph rgroupproject_fall_2012Przybysz, reinhardt ph rgroupproject_fall_2012
Przybysz, reinhardt ph rgroupproject_fall_2012jlreinhardt
 
Opioid Epidemic - Causes, Impact and Future
Opioid Epidemic - Causes, Impact and FutureOpioid Epidemic - Causes, Impact and Future
Opioid Epidemic - Causes, Impact and FutureCitiusTech
 
Primary care in the New Health Economy: Time for a makeover.
Primary care in the New Health Economy: Time for a makeover.Primary care in the New Health Economy: Time for a makeover.
Primary care in the New Health Economy: Time for a makeover.PwC
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalJorgeventura2014
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalGeorgi Daskalov
 
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_KnowHealthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_KnowDebra Harris
 
People, health professionals and health information Working together in 2014
People, health professionals and health information Working together in 2014People, health professionals and health information Working together in 2014
People, health professionals and health information Working together in 2014Health Informatics New Zealand
 
Deloitte innovacion health
Deloitte innovacion healthDeloitte innovacion health
Deloitte innovacion healthgbra80
 
Integration of health records in the prescription drug monitoring program
Integration of health records in the prescription drug monitoring programIntegration of health records in the prescription drug monitoring program
Integration of health records in the prescription drug monitoring programAlayziaHarris
 
Sample HIPAA Training
Sample HIPAA Training Sample HIPAA Training
Sample HIPAA Training Tara Goodwin
 
Tpp 1 walls abou_nader
Tpp 1 walls abou_naderTpp 1 walls abou_nader
Tpp 1 walls abou_naderOPUNITE
 
Chronic Care Improvement: How Medicare Transformation Can Save Lives, Save Mo...
Chronic Care Improvement: How Medicare Transformation Can Save Lives, Save Mo...Chronic Care Improvement: How Medicare Transformation Can Save Lives, Save Mo...
Chronic Care Improvement: How Medicare Transformation Can Save Lives, Save Mo...Steve Brown
 

Similar to In the Patient's Best Interest: Updated HIPAA Guidance Targeted for the Opioid Crisis (20)

Covid 19-survey PWC
Covid 19-survey PWCCovid 19-survey PWC
Covid 19-survey PWC
 
Tx 2 joint presentation
Tx 2 joint presentationTx 2 joint presentation
Tx 2 joint presentation
 
Przybysz, reinhardt ph rgroupproject_fall_2012
Przybysz, reinhardt ph rgroupproject_fall_2012Przybysz, reinhardt ph rgroupproject_fall_2012
Przybysz, reinhardt ph rgroupproject_fall_2012
 
Opioid Epidemic - Causes, Impact and Future
Opioid Epidemic - Causes, Impact and FutureOpioid Epidemic - Causes, Impact and Future
Opioid Epidemic - Causes, Impact and Future
 
Primary care in the New Health Economy: Time for a makeover.
Primary care in the New Health Economy: Time for a makeover.Primary care in the New Health Economy: Time for a makeover.
Primary care in the New Health Economy: Time for a makeover.
 
Prescription Drug Abuse: A Chapter Focus
Prescription Drug Abuse: A Chapter FocusPrescription Drug Abuse: A Chapter Focus
Prescription Drug Abuse: A Chapter Focus
 
Social media and pharma
Social media and pharmaSocial media and pharma
Social media and pharma
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_final
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_final
 
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_KnowHealthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
Healthcasts_Whitepaper_5_Key_Physician_Insights_Pharma_Needs_to_Know
 
People, health professionals and health information Working together in 2014
People, health professionals and health information Working together in 2014People, health professionals and health information Working together in 2014
People, health professionals and health information Working together in 2014
 
Deloitte innovacion health
Deloitte innovacion healthDeloitte innovacion health
Deloitte innovacion health
 
New study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribingNew study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribing
 
Moving Opioid Addiction Treatment Into Primary Medical Care
Moving Opioid Addiction Treatment Into Primary Medical CareMoving Opioid Addiction Treatment Into Primary Medical Care
Moving Opioid Addiction Treatment Into Primary Medical Care
 
Integration of health records in the prescription drug monitoring program
Integration of health records in the prescription drug monitoring programIntegration of health records in the prescription drug monitoring program
Integration of health records in the prescription drug monitoring program
 
Sample HIPAA Training
Sample HIPAA Training Sample HIPAA Training
Sample HIPAA Training
 
Tpp 1 walls abou_nader
Tpp 1 walls abou_naderTpp 1 walls abou_nader
Tpp 1 walls abou_nader
 
Chapter 1[1]
Chapter 1[1]Chapter 1[1]
Chapter 1[1]
 
Ph rs v3
Ph rs   v3Ph rs   v3
Ph rs v3
 
Chronic Care Improvement: How Medicare Transformation Can Save Lives, Save Mo...
Chronic Care Improvement: How Medicare Transformation Can Save Lives, Save Mo...Chronic Care Improvement: How Medicare Transformation Can Save Lives, Save Mo...
Chronic Care Improvement: How Medicare Transformation Can Save Lives, Save Mo...
 

More from PYA, P.C.

“CARES Act Provider Relief Fund: Opportunities, Compliance, and Reporting”
“CARES Act Provider Relief Fund: Opportunities, Compliance, and Reporting”“CARES Act Provider Relief Fund: Opportunities, Compliance, and Reporting”
“CARES Act Provider Relief Fund: Opportunities, Compliance, and Reporting”PYA, P.C.
 
PYA Presented on 2021 E/M Changes and a CARES Act Update During GHA Complianc...
PYA Presented on 2021 E/M Changes and a CARES Act Update During GHA Complianc...PYA Presented on 2021 E/M Changes and a CARES Act Update During GHA Complianc...
PYA Presented on 2021 E/M Changes and a CARES Act Update During GHA Complianc...PYA, P.C.
 
Webinar: “Trick or Treat? October 22nd Revisions to Provider Relief Fund Repo...
Webinar: “Trick or Treat? October 22nd Revisions to Provider Relief Fund Repo...Webinar: “Trick or Treat? October 22nd Revisions to Provider Relief Fund Repo...
Webinar: “Trick or Treat? October 22nd Revisions to Provider Relief Fund Repo...PYA, P.C.
 
“Regulatory Compliance Enforcement Update: Getting Results from the Guidance”
“Regulatory Compliance Enforcement Update: Getting Results from the Guidance” “Regulatory Compliance Enforcement Update: Getting Results from the Guidance”
“Regulatory Compliance Enforcement Update: Getting Results from the Guidance” PYA, P.C.
 
“Federal Legislative and Regulatory Update,” Webinar at DFWHC
 “Federal Legislative and Regulatory Update,” Webinar at DFWHC “Federal Legislative and Regulatory Update,” Webinar at DFWHC
“Federal Legislative and Regulatory Update,” Webinar at DFWHCPYA, P.C.
 
On-Demand Webinar: Compliance With New Provider Relief Funds Reporting Requir...
On-Demand Webinar: Compliance With New Provider Relief Funds Reporting Requir...On-Demand Webinar: Compliance With New Provider Relief Funds Reporting Requir...
On-Demand Webinar: Compliance With New Provider Relief Funds Reporting Requir...PYA, P.C.
 
Webinar: “While You Were Sleeping…Proposed Rule Positioned to Significantly I...
Webinar: “While You Were Sleeping…Proposed Rule Positioned to Significantly I...Webinar: “While You Were Sleeping…Proposed Rule Positioned to Significantly I...
Webinar: “While You Were Sleeping…Proposed Rule Positioned to Significantly I...PYA, P.C.
 
Webinar: “Cybersecurity During COVID-19: A Look Behind the Scenes
Webinar: “Cybersecurity During COVID-19: A Look Behind the ScenesWebinar: “Cybersecurity During COVID-19: A Look Behind the Scenes
Webinar: “Cybersecurity During COVID-19: A Look Behind the ScenesPYA, P.C.
 
Webinar: CMS Pricing Transparency — Final Rule Requirements, Compliance Chall...
Webinar: CMS Pricing Transparency — Final Rule Requirements, Compliance Chall...Webinar: CMS Pricing Transparency — Final Rule Requirements, Compliance Chall...
Webinar: CMS Pricing Transparency — Final Rule Requirements, Compliance Chall...PYA, P.C.
 
Federal Regulatory Update
Federal Regulatory UpdateFederal Regulatory Update
Federal Regulatory UpdatePYA, P.C.
 
Webinar: Post-Pandemic Provider Realignment — Navigating An Uncertain Market
Webinar: Post-Pandemic Provider Realignment — Navigating An Uncertain MarketWebinar: Post-Pandemic Provider Realignment — Navigating An Uncertain Market
Webinar: Post-Pandemic Provider Realignment — Navigating An Uncertain MarketPYA, P.C.
 
07 24-20 pya webinar covid physician compensation
07 24-20 pya webinar covid physician compensation07 24-20 pya webinar covid physician compensation
07 24-20 pya webinar covid physician compensationPYA, P.C.
 
Engaging Your Board In the COVID-19 Era
Engaging Your Board In the COVID-19 EraEngaging Your Board In the COVID-19 Era
Engaging Your Board In the COVID-19 EraPYA, P.C.
 
Webinar: Free Money with Strings Attached – Cares Act Considerations for Fron...
Webinar: Free Money with Strings Attached – Cares Act Considerations for Fron...Webinar: Free Money with Strings Attached – Cares Act Considerations for Fron...
Webinar: Free Money with Strings Attached – Cares Act Considerations for Fron...PYA, P.C.
 
Webinar: “Got a Payroll? Don’t Leave Money on the Table”
Webinar: “Got a Payroll? Don’t Leave Money on the Table”Webinar: “Got a Payroll? Don’t Leave Money on the Table”
Webinar: “Got a Payroll? Don’t Leave Money on the Table”PYA, P.C.
 
Webinar: So You Have a PPP Loan. Now What?
Webinar: So You Have a PPP Loan. Now What?Webinar: So You Have a PPP Loan. Now What?
Webinar: So You Have a PPP Loan. Now What?PYA, P.C.
 
Webinar: “Making It Work—Physician Compensation During the COVID-19 Pandemic”
Webinar: “Making It Work—Physician Compensation During the COVID-19 Pandemic”Webinar: “Making It Work—Physician Compensation During the COVID-19 Pandemic”
Webinar: “Making It Work—Physician Compensation During the COVID-19 Pandemic”PYA, P.C.
 
Webinar: “Provider Relief Fund Payments – What We Know, What We Don’t Know, W...
Webinar: “Provider Relief Fund Payments – What We Know, What We Don’t Know, W...Webinar: “Provider Relief Fund Payments – What We Know, What We Don’t Know, W...
Webinar: “Provider Relief Fund Payments – What We Know, What We Don’t Know, W...PYA, P.C.
 
Webinar: “Hospitals, Capital, and Cashflow Under COVID-19”
Webinar: “Hospitals, Capital, and Cashflow Under COVID-19”Webinar: “Hospitals, Capital, and Cashflow Under COVID-19”
Webinar: “Hospitals, Capital, and Cashflow Under COVID-19”PYA, P.C.
 
PYA Webinar: “Additional Expansion of Medicare Telehealth Coverage During COV...
PYA Webinar: “Additional Expansion of Medicare Telehealth Coverage During COV...PYA Webinar: “Additional Expansion of Medicare Telehealth Coverage During COV...
PYA Webinar: “Additional Expansion of Medicare Telehealth Coverage During COV...PYA, P.C.
 

More from PYA, P.C. (20)

“CARES Act Provider Relief Fund: Opportunities, Compliance, and Reporting”
“CARES Act Provider Relief Fund: Opportunities, Compliance, and Reporting”“CARES Act Provider Relief Fund: Opportunities, Compliance, and Reporting”
“CARES Act Provider Relief Fund: Opportunities, Compliance, and Reporting”
 
PYA Presented on 2021 E/M Changes and a CARES Act Update During GHA Complianc...
PYA Presented on 2021 E/M Changes and a CARES Act Update During GHA Complianc...PYA Presented on 2021 E/M Changes and a CARES Act Update During GHA Complianc...
PYA Presented on 2021 E/M Changes and a CARES Act Update During GHA Complianc...
 
Webinar: “Trick or Treat? October 22nd Revisions to Provider Relief Fund Repo...
Webinar: “Trick or Treat? October 22nd Revisions to Provider Relief Fund Repo...Webinar: “Trick or Treat? October 22nd Revisions to Provider Relief Fund Repo...
Webinar: “Trick or Treat? October 22nd Revisions to Provider Relief Fund Repo...
 
“Regulatory Compliance Enforcement Update: Getting Results from the Guidance”
“Regulatory Compliance Enforcement Update: Getting Results from the Guidance” “Regulatory Compliance Enforcement Update: Getting Results from the Guidance”
“Regulatory Compliance Enforcement Update: Getting Results from the Guidance”
 
“Federal Legislative and Regulatory Update,” Webinar at DFWHC
 “Federal Legislative and Regulatory Update,” Webinar at DFWHC “Federal Legislative and Regulatory Update,” Webinar at DFWHC
“Federal Legislative and Regulatory Update,” Webinar at DFWHC
 
On-Demand Webinar: Compliance With New Provider Relief Funds Reporting Requir...
On-Demand Webinar: Compliance With New Provider Relief Funds Reporting Requir...On-Demand Webinar: Compliance With New Provider Relief Funds Reporting Requir...
On-Demand Webinar: Compliance With New Provider Relief Funds Reporting Requir...
 
Webinar: “While You Were Sleeping…Proposed Rule Positioned to Significantly I...
Webinar: “While You Were Sleeping…Proposed Rule Positioned to Significantly I...Webinar: “While You Were Sleeping…Proposed Rule Positioned to Significantly I...
Webinar: “While You Were Sleeping…Proposed Rule Positioned to Significantly I...
 
Webinar: “Cybersecurity During COVID-19: A Look Behind the Scenes
Webinar: “Cybersecurity During COVID-19: A Look Behind the ScenesWebinar: “Cybersecurity During COVID-19: A Look Behind the Scenes
Webinar: “Cybersecurity During COVID-19: A Look Behind the Scenes
 
Webinar: CMS Pricing Transparency — Final Rule Requirements, Compliance Chall...
Webinar: CMS Pricing Transparency — Final Rule Requirements, Compliance Chall...Webinar: CMS Pricing Transparency — Final Rule Requirements, Compliance Chall...
Webinar: CMS Pricing Transparency — Final Rule Requirements, Compliance Chall...
 
Federal Regulatory Update
Federal Regulatory UpdateFederal Regulatory Update
Federal Regulatory Update
 
Webinar: Post-Pandemic Provider Realignment — Navigating An Uncertain Market
Webinar: Post-Pandemic Provider Realignment — Navigating An Uncertain MarketWebinar: Post-Pandemic Provider Realignment — Navigating An Uncertain Market
Webinar: Post-Pandemic Provider Realignment — Navigating An Uncertain Market
 
07 24-20 pya webinar covid physician compensation
07 24-20 pya webinar covid physician compensation07 24-20 pya webinar covid physician compensation
07 24-20 pya webinar covid physician compensation
 
Engaging Your Board In the COVID-19 Era
Engaging Your Board In the COVID-19 EraEngaging Your Board In the COVID-19 Era
Engaging Your Board In the COVID-19 Era
 
Webinar: Free Money with Strings Attached – Cares Act Considerations for Fron...
Webinar: Free Money with Strings Attached – Cares Act Considerations for Fron...Webinar: Free Money with Strings Attached – Cares Act Considerations for Fron...
Webinar: Free Money with Strings Attached – Cares Act Considerations for Fron...
 
Webinar: “Got a Payroll? Don’t Leave Money on the Table”
Webinar: “Got a Payroll? Don’t Leave Money on the Table”Webinar: “Got a Payroll? Don’t Leave Money on the Table”
Webinar: “Got a Payroll? Don’t Leave Money on the Table”
 
Webinar: So You Have a PPP Loan. Now What?
Webinar: So You Have a PPP Loan. Now What?Webinar: So You Have a PPP Loan. Now What?
Webinar: So You Have a PPP Loan. Now What?
 
Webinar: “Making It Work—Physician Compensation During the COVID-19 Pandemic”
Webinar: “Making It Work—Physician Compensation During the COVID-19 Pandemic”Webinar: “Making It Work—Physician Compensation During the COVID-19 Pandemic”
Webinar: “Making It Work—Physician Compensation During the COVID-19 Pandemic”
 
Webinar: “Provider Relief Fund Payments – What We Know, What We Don’t Know, W...
Webinar: “Provider Relief Fund Payments – What We Know, What We Don’t Know, W...Webinar: “Provider Relief Fund Payments – What We Know, What We Don’t Know, W...
Webinar: “Provider Relief Fund Payments – What We Know, What We Don’t Know, W...
 
Webinar: “Hospitals, Capital, and Cashflow Under COVID-19”
Webinar: “Hospitals, Capital, and Cashflow Under COVID-19”Webinar: “Hospitals, Capital, and Cashflow Under COVID-19”
Webinar: “Hospitals, Capital, and Cashflow Under COVID-19”
 
PYA Webinar: “Additional Expansion of Medicare Telehealth Coverage During COV...
PYA Webinar: “Additional Expansion of Medicare Telehealth Coverage During COV...PYA Webinar: “Additional Expansion of Medicare Telehealth Coverage During COV...
PYA Webinar: “Additional Expansion of Medicare Telehealth Coverage During COV...
 

Recently uploaded

dehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetdehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMuzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510Vipesco
 
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girl
Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girlKolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girl
Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girlonly4webmaster01
 
Thrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetThrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In ChandigarhSheetaleventcompany
 
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...Ahmedabad Call Girls
 
neemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
neemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetneemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
neemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetErnakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Chandigarh
 
Vip Call Girls Makarba 👙 6367187148 👙 Genuine WhatsApp Number for Real Meet
Vip Call Girls Makarba 👙 6367187148 👙 Genuine WhatsApp Number for Real MeetVip Call Girls Makarba 👙 6367187148 👙 Genuine WhatsApp Number for Real Meet
Vip Call Girls Makarba 👙 6367187148 👙 Genuine WhatsApp Number for Real MeetAhmedabad Call Girls
 
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetNanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in LahoreBest Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in LahoreDeny Daniel
 
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...mahaiklolahd
 
bhopal Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhopal Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetbhopal Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhopal Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
Call Girls Service In Goa 💋 9316020077💋 Goa Call Girls By Russian Call Girl...
Call Girls Service In Goa  💋 9316020077💋 Goa Call Girls  By Russian Call Girl...Call Girls Service In Goa  💋 9316020077💋 Goa Call Girls  By Russian Call Girl...
Call Girls Service In Goa 💋 9316020077💋 Goa Call Girls By Russian Call Girl...russian goa call girl and escorts service
 
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near MeVIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Memriyagarg453
 
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetHubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
Mathura Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mathura Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMathura Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mathura Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 

Recently uploaded (20)

dehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetdehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMuzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
 
Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510
 
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
 
Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girl
Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girlKolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girl
Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girl
 
Thrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetThrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
 
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...
 
neemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
neemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetneemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
neemuch Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetErnakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Vip Call Girls Makarba 👙 6367187148 👙 Genuine WhatsApp Number for Real Meet
Vip Call Girls Makarba 👙 6367187148 👙 Genuine WhatsApp Number for Real MeetVip Call Girls Makarba 👙 6367187148 👙 Genuine WhatsApp Number for Real Meet
Vip Call Girls Makarba 👙 6367187148 👙 Genuine WhatsApp Number for Real Meet
 
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetNanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in LahoreBest Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
 
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
 
bhopal Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhopal Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetbhopal Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhopal Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Call Girls Service In Goa 💋 9316020077💋 Goa Call Girls By Russian Call Girl...
Call Girls Service In Goa  💋 9316020077💋 Goa Call Girls  By Russian Call Girl...Call Girls Service In Goa  💋 9316020077💋 Goa Call Girls  By Russian Call Girl...
Call Girls Service In Goa 💋 9316020077💋 Goa Call Girls By Russian Call Girl...
 
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near MeVIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
 
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetHubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Mathura Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mathura Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMathura Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mathura Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 

In the Patient's Best Interest: Updated HIPAA Guidance Targeted for the Opioid Crisis

  • 1. Susan Thomas CHC, CIA, CRMA, CPC Compliance Manager-PYA 2018 KHIMA ANNUAL MEETING In the Patient’s Best Interest: Updated HIPAA Guidance Targeted for the Opioid Crisis
  • 2. Prepared for 2018 KHIMA Annual Meeting Page 1 Objectives  Review of HIPAA privacy standards  Define “in the patient’s best interest”  The opioid crisis  Features of the updated guidance  Application considerations  Great! Now what do we do?
  • 3. Prepared for 2018 KHIMA Annual Meeting Page 2 HIPAA Privacy Standards  The privacy standards define the boundaries for the appropriate use of health information to support TPO:  Treatment  Payment  Operations  Under HIPAA, healthcare providers must:  Notify patients of privacy rights  Allow patients to see their medical records  Implement privacy procedures  Provide training for employees  Designate an individual to be responsible for seeing that privacy procedures are adopted and followed  Keep patient records secure
  • 4. Prepared for 2018 KHIMA Annual Meeting Page 3 HIPAA Privacy Standards Covered Entities Healthcare Organizations Healthcare Plans/Payers Healthcare Clearinghouse  At the core of HIPAA is the definition of covered entities to whom it pertains  A covered entity is a healthcare organization such as a provider, a healthcare clearinghouse, or a healthcare plan such as Medicare or commercial payers  The HIPAA Standards require covered entities to:  Implement privacy procedures and train their employees to follow the procedures  Designate an individual to be responsible for ensuring that the privacy procedures are followed  Secure patient records so they are not easily accessible to those who do not need them
  • 5. Prepared for 2018 KHIMA Annual Meeting Page 4 In the Patient’s Best Interest  A fundamental consideration:  Patient autonomy meets medical responsibility  The balance of protection from harm with the provision of necessary services  Who says?  The attending physician often holds the ultimate responsibility to determine if a patient is able to make sound healthcare decisions  The courts may be involved which can be time- consuming and dramatic  Advanced directives and surrogate decision-making
  • 6. Prepared for 2018 KHIMA Annual Meeting Page 5 In the Patient’s Best Interest  Healthcare providers often find themselves faced with circumstances in which they have to make decisions for an incapacitated patient  Nowhere is the issue of protection versus provision more evident than in the midst of the opioid crisis
  • 7. Prepared for 2018 KHIMA Annual Meeting Page 6 The Opioid Crisis  The opioid epidemic is the leading cause of death in the U.S. among adults under 501  Life expectancy in the U.S. fell for the second year in a row in 2016 – attributed to fatal opioid overdoses2  Emergency Department visits for opioid overdose up 30% in 20173  Drugs include hydrocodone (Vicodin), oxycodone (OxyContin), morphine, codeine, fentanyl, methadone, heroin  Can be taken orally, injected, inhaled, and/or smoked 1. https://www.nytimes.com/interactive/2017/06/05/upshot/opioid-epidemic-drug-overdose-deaths-are-rising-faster-than- ever.html. 2. https://www.pri.org/stories/2017-12-21/us-life-expectancy-fell-2016-second-year-row. 3. https://www.cnn.com/2018/03/06/health/opioid-overdose-emergency-departments-cdc-study/index.html.
  • 8. Prepared for 2018 KHIMA Annual Meeting Page 7 The Opioid Crisis  In 2012, 259 million prescriptions were written for opioids, which is more than enough to give every American adult their own bottle of pills4  Four in five new heroin users started out by misusing prescription painkillers5 4. Centers for Disease Control and Prevention. (2014). Opioid Painkiller Prescribing, Where You Live Makes a Difference. Atlanta, GA: Centers for Disease Control and Prevention. Available at http://www.cdc.gov/vitalsigns/opioid-prescribing/. 5. Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013 Sep 1;132(1-2):95-100. doi: 10.1016/j.drugalcdep.2013.01.007. Epub 2013 Feb 12.
  • 9. Prepared for 2018 KHIMA Annual Meeting Page 8 The Opioid Crisis Opioid addiction does not discriminate  Adolescents (12 to 17 years old)6  The prescribing rates for prescription opioids among adolescents and young adults nearly doubled from 1994 to 2007  Most adolescents who misuse prescription pain relievers are given them for free by a friend or relative 6. https://www.asam.org/docs/default-source/advocacy/opioid-addiction-disease-facts-figures.pdf.
  • 10. Prepared for 2018 KHIMA Annual Meeting Page 9 The Opioid Crisis Opioid addiction does not discriminate  Women7  Women are more likely to have chronic pain, be prescribed prescription pain relievers, be given higher doses, and use them for longer time periods than men  Women may become dependent on prescription pain relievers more quickly than men  48,000 women died of prescription pain reliever overdoses between 1999 and 2010 7. Centers for Disease Control and Prevention. (2013). Prescription Painkiller Overdoses: A Growing Epidemic, Especially Among Women. Atlanta, GA: Centers for Disease Control and Prevention. Available at http://www.cdc.gov/vitalsigns/prescriptionpainkilleroverdoses/index.html.
  • 11. Prepared for 2018 KHIMA Annual Meeting Page 10 The Opioid Crisis Opioid addiction does not discriminate  Elderly8  Older adults use more prescription drugs than do any other age group  Elderly patients often see multiple healthcare providers and obtain multiple prescriptions  Over 40% of older adults have chronic pain that is often treated with opioids, sometimes for long periods of time  Opioid use among older adults increases risk for falls, delirium, fractures, pneumonia, and all-cause mortality 8. https://www.aarp.org/content/dam/aarp/ppi/2017/07/prescription-drug-abuse-among-older-adults.pdf.
  • 12. Prepared for 2018 KHIMA Annual Meeting Page 11 Features of the Updated Guidance  Current HIPAA regulations allow healthcare providers to share information in certain emergency or dangerous situations  Misunderstandings about HIPAA can create obstacles to family support that is crucial to the proper care and treatment of a crisis situation
  • 13. Prepared for 2018 KHIMA Annual Meeting Page 12 Features of the Updated Guidance  Newly released HIPAA guidelines from OCR include:  Sharing information related to mental health and substance use disorder treatment with a patient's family, friends, and others involved in the patient’s care or payment for care  Collaboration with HHS partner agencies to identify and develop model programs and materials for training related to mental health or substance use disorder treatment  HIPAA and research, as called for in the Cures Act  Launch of a working group to study use of Protected Health Information, or PHI, for research purposes
  • 14. Prepared for 2018 KHIMA Annual Meeting Page 13 Features of the Updated Guidance  The role that caregivers provide to individuals with a substance abuse disorder in support of treatment and recovery  Must be able to notify caregivers in emergency situations and coordinate care for acute and ongoing treatment
  • 15. Prepared for 2018 KHIMA Annual Meeting Page 14 Application Considerations  PHI can be shared with a patient’s relatives or friends who are involved in the patient’s care, or if the sharing is necessary to identify, locate, or notify family members  Incapacitation: An unfortunate, but important information-sharing issue to address with substance abuse
  • 16. Prepared for 2018 KHIMA Annual Meeting Page 15 Application Considerations  Family and close friends involved in the care of the incapacitated patient are allowed to obtain specifically related information if the release of information is in the best interest of the patient  Sharing unrelated medical information is never allowed without the patient’s permission  If the patient poses a serious and imminent health and safety threat, healthcare providers can inform family, friends, or caregivers to prevent or lessen the likelihood of harm
  • 17. Prepared for 2018 KHIMA Annual Meeting Page 16 Application Considerations  A patient’s incapacity may be temporary, requiring healthcare providers to use their professional judgement  If the patient has capacity, the patient has the right to object to further disclosures of information  The provider may still share information with the patient’s friends or family under the “threat to health or safety” circumstances
  • 18. Prepared for 2018 KHIMA Annual Meeting Page 17 Great! Now what do we do?  New guidance does not include new statutory requirements  Helps debunk persistent myths about what type of information can be shared with family members and others  Describes when PHI can be shared in the urgent situations caused by substance abuse
  • 19. Prepared for 2018 KHIMA Annual Meeting Page 18  OCR’s updated HIPAA guidance DOES NOT supersede state laws or other federal guidelines, including the federal confidentiality regulations (i.e., 42 CFR Part 2)  The “Part 2” regulations pertain to patient records maintained in connection with certain federally assisted substance use disorder treatment programs  Part 2 could prohibit some, or all, of the disclosures which OCR has now clarified are permitted under HIPAA Great! Now what do we do?
  • 20. Prepared for 2018 KHIMA Annual Meeting Page 19 Great! Now what do we do?  Provide the updated guidance information with emergency room physicians, nurses, clinicians, and facilities who treat persons with substance abuse problems
  • 21. Prepared for 2018 KHIMA Annual Meeting Page 20 Great! Now what do we do? Fact Sheets
  • 22. Prepared for 2018 KHIMA Annual Meeting Page 21 Great! Now what do we do?  Examine organizational policies and procedures to properly balance the protection of privacy with providing care in the best interest of the patient Image Source: (2017) Justice Pixabay #311699, Pixabay.com.
  • 23. Prepared for 2018 KHIMA Annual Meeting Page 22 Closing thoughts . . . “HHS is using every tool at its disposal to help communities devastated by opioids including educating families and doctors on how they can share information to help save the lives of loved ones.” – Roger Severino, Director of OCR “When someone is unconscious, you should violate their privacy to save a life.” – Dr. Deborah Peel, Founder and President, Patient Privacy Rights “I don’t think we should make it right to kill yourself easily without the intervention of your loved ones.” – Governor Chris Christie, Chairman of the President’s Opioid Commission
  • 24. Prepared for 2018 KHIMA Annual Meeting Page 23 Questions? Image Source: (2017) Questions Pixabay #1090830, Pixabay.com.
  • 25. Prepared for 2018 KHIMA Annual Meeting Page 24 THANK YOU! Susan Thomas CHC,® CIA, CRMA, CPC® Manager – PYA, P.C. sthomas@pyapc.com